Search

everythinglearnresearchcommunity

for

Search:↓

Redensyl, saw palmetto, and biotin with platelet-rich plasma is a better treatment for hair loss than Procapil with platelet-rich plasma.

Zinc is effective for treating various skin conditions, including warts and acne.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Melatonin may inhibit melanoma growth and has potential as a cancer therapy aid, but its effects on human skin pigmentation need more research.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Men are increasingly interested in cosmetic treatments that enhance masculinity and address aging without downtime, with tailored approaches for different ethnicities and a focus on hair restoration and body contouring.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

PPX causes much less hair loss than traditional taxanes.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

The drug combination was safe and showed promise in treating advanced tumors.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

The new nanoparticles could improve melanoma treatment by working better than current options.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

The treatment was effective and tolerable for advanced gastric cancer.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.